Business Context and Reporting Period
Company: Voyager Technologies, Inc. (VOYG)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2026
Business Overview: Voyager is a defense and space technology company operating in two segments: Defense and Space Technologies and Starlab Space Stations. The company is developing Starlab, a commercial space station intended to replace the ISS, and provides mission-critical solutions to government and commercial customers.
Key Financial Metrics
| Metric (in thousands) | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Sales | $35,246 | $34,507 |
| Gross Profit (Loss) | $(1,546) | $5,585 |
| Operating Loss | $(44,647) | $(26,289) |
| Net Loss | $(45,944) | $(27,929) |
| Net Loss Attributable to Voyager | $(43,983) | $(26,938) |
| Adjusted EBITDA | $(33,331) | $(21,356) |
| Cash and Cash Equivalents (End of Period) | $429,361 | $175,488 |
| Free Cash Flow | $(66,794) | $(23,324) |
| Total Debt (Convertible Notes, Net) | $448,268 | N/A |
Note: Q1 2025 figures are presented for comparison; the company completed its IPO in June 2025, altering capital structure and share counts.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 2.1% year-over-year to $35.2 million, driven by a $1.7 million increase in U.S. Government sales, partially offset by a decline in international sales.
- Margin Compression: The company reported a gross loss of $1.5 million compared to a gross profit of $5.6 million in the prior year. This was primarily due to a 27.2% increase in cost of sales, driven by higher program input costs and firm fixed-price program growth.
- Expense Increases:
- SG&A: Increased 19.3% to $31.4 million due to headcount growth and stock-based compensation related to IPO awards.
- R&D: Increased 85.9% to $7.5 million, driven by strategic systems development.
- Amortization: Increased 173.4% to $4.2 million due to full-period amortization of intangibles acquired in 2025 (ExoTerra, Estes, EMSI, OPC).
- Segment Performance:
- Defense and Space Technologies: Net sales rose slightly to $36.2 million, but Adjusted EBITDA deteriorated to a loss of $11.5 million (from a loss of $1.1 million) due to R&D investments and program cost growth.
- Starlab Space Stations: Reported no revenue. Adjusted EBITDA loss widened to $5.4 million (from $2.8 million) due to increased labor and non-labor R&D expenses.
- Liquidity: Cash balances decreased by $62.0 million during the quarter due to significant operating and investing outflows, though total liquidity remains robust at $641.4 million including revolver capacity.
Guidance, Outlook, and Risks
- Backlog: Total backlog stands at $275.3 million, with $153.2 million funded. Management expects to convert 71.2% of the funded backlog into revenue for the remainder of 2026. 83.5% of the funded backlog is attributed to the U.S. Government.
- Starlab Funding: The company has cumulatively earned $207.2 million of a $217.5 million NASA grant for Starlab development, with $10.3 million remaining eligible as of March 31, 2026. Milestone payments are expected through June 2026.
- Capital Structure:
- Convertible Notes: $460.0 million principal outstanding in 2030 Convertible Notes (0.75% interest).
- Credit Facilities: $200.0 million senior secured revolving credit facility (undrawn) and a $20.0 million Starlab Credit Facility (undrawn).
- Risks and Contingencies:
- Customer Concentration: Heavy reliance on U.S. Government funding creates exposure to budgetary constraints and political shifts.
- Profitability: The company has an accumulated deficit of $429.9 million and expects to incur losses as it scales operations and invests in Starlab.
- Contract Risks: Exposure to cost overruns on firm fixed-price contracts and potential termination for convenience by government customers.
Investor Verification Checklist
- Starlab Milestone Timing: Verify the schedule for the remaining $10.3 million in NASA grant funding and the timeline for revenue generation from the Starlab station post-2030.
- Fixed-Price Contract Exposure: Assess the specific firm fixed-price contracts driving the gross margin decline and the adequacy of loss reserves.
- Cash Burn Rate: Monitor the trajectory of free cash flow, which was negative $66.8 million in Q1, against the $429 million cash balance to determine runway without additional financing.
- Convertible Note Conversion: Review the terms of the $460 million 2030 Convertible Notes, specifically the conversion price ($30.98) and potential dilution if the stock price exceeds 130% of the conversion price.
- Acquisition Integration: Evaluate the performance of 2025 acquisitions (ExoTerra, Estes, EMSI, OPC) and whether the increased amortization expense is yielding expected synergies.